Abstract
Pegylated interferon (IFN) in combination with ribavirin is currently the standard of care for the treatment of hepatitis C virus (HCV) infection, but achieves a sustained viral response in only 50%-60% of patients. Interestingly, patients with HCV genotypes that are more resistant to treatment also demonstrate insulin resistance. Thus we sought to examine the effects of insulin sensitisers on the response of HCV to IFN.
| Original language | English |
|---|---|
| Pages (from-to) | A121-A121 |
| Number of pages | 1 |
| Journal | Journal of Gastroenterology and Hepatology |
| Volume | 25 |
| Issue number | Suppl. S3 |
| Publication status | Published - 2010 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- hepatitis C virus
- intererfon
- antiviral agents
Fingerprint
Dive into the research topics of 'Combination treatment with insulin sensitisers improves the antiviral effect of interferon against hepatitis C virus'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver